BlackRock Amends Veracyte Stake, Signals Passive Investment Update
Ticker: VCYT · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 1384101
| Field | Detail |
|---|---|
| Company | Veracyte, Inc. (VCYT) |
| Form Type | SC 13G/A |
| Filed Date | Jan 24, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock just updated its Veracyte stake, showing a passive investment change.**
AI Summary
BlackRock Inc. filed an amended Schedule 13G/A on January 24, 2024, indicating a change in its ownership of Veracyte, Inc. common stock as of December 31, 2023. This filing, Amendment No. 6, updates BlackRock's passive investment position in the medical diagnostics company. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in confidence or strategy regarding Veracyte's future performance.
Why It Matters
This filing shows BlackRock's updated ownership in Veracyte, Inc., providing transparency into a significant institutional investor's position, which can influence market perception.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should note BlackRock's continued passive interest in Veracyte, Inc. and consider this as part of the broader institutional sentiment when evaluating their own investment decisions.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Veracyte, Inc. (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 24, 2024 (date) — the date the SC 13G/A was filed
- Amendment No. 6 (number) — the specific amendment number of the filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 6)' sections.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., as indicated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
What company's securities are the subject of this filing?
The securities of VERACYTE, INC. are the subject of this filing, as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VERACYTE, INC.' and 'VERACYTE, INC (Name of Issuer)'.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified in the 'Date of Event Which Requires Filing of this Statement' section.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the '[X] Rule 13d-1(b)' checkbox.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding VERACYTE, INC. (VCYT).